ப்ரொஃபைல்ஸ் ஆஃப் விசை ம்ட்கஷ நிறுவனங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரொஃபைல்ஸ் ஆஃப் விசை ம்ட்கஷ நிறுவனங்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரொஃபைல்ஸ் ஆஃப் விசை ம்ட்கஷ நிறுவனங்கள் Today - Breaking & Trending Today

Global Molecular Diagnostics for Infectious Disease Market 2021-2025: New Genotypes Creating New Markets / Aging Population a Boon for All Diagnostics / Developing World Driving ID Dx Growth

8.2.3 Wellness Hurts
8.3 Instrumentation and Automation
8.3.2 The Shrinking Machine
8.4 Diagnostic Technology Development
8.4.2 POCT/Self Testing as a Disruptive Force
8.4.3 The Genetics Play - One Test for All Known Infections
8.4.4 Antibiotic Resistance Genes - Simplifying Diagnostics
9 Molecular Dx - Infectious Disease Recent Developments
9.1 Recent Developments - Importance and How to Use This Section
9.1.1 Importance of These Developments
9.1.2 How to Use This Section
9.2 Roche to Acquire GenMark Diagnostics for $1.8B
9.3 Lucira Health Focuses on User Friendly Approach to Home Testing
9.4 Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO
9.5 Fluidigm Plans Durable Diagnostics, Clinical Business
9.6 Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M ....

United States , Qiagen Gmb , Siemens Healthineers , Akonni Biosystems , Laura Wood , Academic Research Lab , Bosch Healthcare Solutions Gmb , Testing Lab , Central Lab , Technology Development , Clinical Laboratory Market Segments , Binx Health , Cue Health , Enzo Life Sciences Inc , Qiagen Respiratory Panel , Idx Technology , Office Hours Call , Luminex Corp , Business Development Staff , E St Office Hours Call , Bio Rad Laboratories Inc , Clinical Laboratory Testing , Physician Office Labs , Thermo Fisher Scientific Inc , Profiles Of Key Mdx Companies , Infectious Disease Dx Firm Talis Biomedical ,

Global Molecular Diagnostics for Cancer Markets Report 2021-2025: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs; COVID-19 Causes Resources Shift

7 Molecular Diagnostics Recent Developments
7.1 Recent Developments - Importance and How to Use This Section
7.1.1 Importance of These Developments
7.1.2 How to Use This Section
7.2 Nucleix to Invest in Early-Stage Lung Cancer Dx
7.3 Invitae to Acquire Genosity for $200M
7.4 Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test
7.5 Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience
7.6 Natera Revenues Grow 35 Percent
7.7 AnchorDx Closes $40M Financing Round
7.8 Exact Sciences Strategy for End-to-End Cancer Testing
7.9 Genomics England: Whole Genome Sequencing for Cancer Patients to Launch
7.10 Singlera Genomics Closes $150M Funding for Cancer Screening
7.11 Biocartis GeneproDx, Endpoint Health Collaborate on Tests for Idylla Platform ....

United States , New York , Miltenyi Biotec , Yourgene Elucigene , Qiagen Gmbh , Sysmex Inostics , Bristol Myers Squibb , Siemens Healthineers , Biocartis Geneprodx , Laura Wood , Academic Research Lab , Testing Lab , Mdx Companion Dx Development , Sciences Strategy For Cancer Testing , Technology Development , Us Medicare Expenditures For Laboratory Testing , Singlera Genomics Inc , Physician Lab , Mdx Clinical Laboratory , Servier Sign Liquid Biopsy Services Deal , Enzo Life Sciences Inc , Office Hours Call , Biodesix Inc , Datar Cancer Genetics , Fluidigm Corp , Accuragen Inc ,

Global Cancer Molecular Diagnostics Markets 2021-2025 - New Diagnostics Create New Markets

A market with fundamental growth factors is impacted by the COVID-19 Pandemic.
Molecular Diagnostics for Cancer is positioned to directly benefit from the explosion in genomics knowledge but shifting resources to deal with the COVID emergency may interrupt growth. Learn all about it in this new report. the publisher includes a special segment, Cancer Companion Diagnostics, a new segment of the market that is reshaping the industry. And now over 130 companies are profiled. A range of dynamic trends are pushing market growth and company valuations.
Working against this dynamic market are the forces of the COVID Driven Recession. The publisher s latest numbers factor in the different COVID forces, their timing, and their effect on growth. ....

New York , United States , Miltenyi Biotec , Yourgene Elucigene , Qiagen Gmbh , Sysmex Inostics , Bristol Myers Squibb , Siemens Healthineers , Laura Wood , Academic Research Lab , Testing Lab , Mdx Companion Dx Development , Public National , Technology Development , Us Medicare Expenditures For Laboratory Testing , Physician Lab , Physician Office Lab , Servier Sign Liquid Biopsy Services Deal , Enzo Life Sciences Inc , Office Hours Call , Biodesix Inc , Datar Cancer Genetics , Fluidigm Corp , Accuragen Inc , Business Development Staff , Genefirst Ltd ,

Global Infectious Disease Molecular Diagnostics Markets 2021: Focus on HIV, HBV, HCV, HPV, Influenza, CTGC, Tuberculosis, MRSA, VRE & Blood Screening

4.2.3 Wellness Hurts
4.3 Instrumentation and Automation
4.3.2 The Shrinking Machine.
4.4 Diagnostic Technology Development
4.4.2 POCT/Self Testing as a Disruptive Force
4.4.3 The Genetics Play - One Test for All Known Infections
4.4.4 Antibiotic Resistance Genes - Simplifying Diagnostics
5. Molecular Dx - Infectious Disease Recent Developments
Recent Developments- Importance and How to Use This Section
Importance of These Developments
Fusion Genomics to Assess NGS-Based Respiratory Tract Infection Assay
New Genomic Tests Diagnose Deadly Infections Faster
Biotia Raises $2.4M Seed Round
STDs resurge in US
Cell-Free DNA Used for Infectious Disease Testing
One BioMed Raises $5M
iCubate, Wondfo Biotech Form Chinese JV to Develop MDx Assays ....

Siemens Healthineers , Akonni Biosystems , Laura Wood , Bosch Healthcare Solutions Gmb , Public National , Dx Firm Sherlock Biosciences , Central Lab , Technology Development , Thermo Fisher , Mesa Biotech Inc , Clinical Laboratory Market Segments , Physician Office Lab , Beckman Coulter , Custom Research , Sekisui Diagnostics Enters Strategic Alliance , Biocode Syndromic Gastrointestinal Pathogen Panel , Office Hours Call , Biocartis Immunexpress Sign Partnership For Sepsis , E St Office Hours Call , Profiles Of Key Mdx Companies , Clinical Laboratory Testing , Infectious Disease , Care Market Analysis , Executive Guides , Molecular Diagnostics , Topics Covered ,

Global Infectious Disease Molecular Diagnostics Markets Report 2021 - Multiplex Testing Threatens Existing Assays / Test Speed Taking Centre Stage.

Global Infectious Disease Molecular Diagnostics Markets Report 2021 - Multiplex Testing Threatens Existing Assays / Test Speed Taking Centre Stage.
February 02, 2021 04:38 ET
| Source:
Research and Markets
Research and Markets
Dublin, IRELAND
Multiplex testing threatens existing infectious disease practice. The microbiology lab may disappear.
The Molecular Diagnostics - Infectious Disease sector of the clinical diagnostics industry is poised for record growth.
A market that just keeps on growing. In spite of the steady decline of disease prevalence, the diagnostic sector keeps growing. Find out why in the informative report. And find out about the exciting developments in multiplex assays which threaten to change diagnosis and treatment while limiting the threat of anti microbial drug resistance. ....

Siemens Healthineers , Akonni Biosystems , Laura Wood , Bosch Healthcare Solutions Gmb , Public National , Dx Firm Sherlock Biosciences , Central Lab , Technology Development , Thermo Fisher , Mesa Biotech Inc , Clinical Laboratory Market Segments , Physician Office Lab , Beckman Coulter , Custom Research , Sekisui Diagnostics Enters Strategic Alliance , Biocode Syndromic Gastrointestinal Pathogen Panel , Office Hours Call , Biocartis Immunexpress Sign Partnership For Sepsis , E St Office Hours Call , Profiles Of Key Mdx Companies , Clinical Laboratory Testing , Infectious Disease , Care Market Analysis , Executive Guides , Molecular Diagnostics , Topics Covered ,